DK3463310T3 - Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte - Google Patents

Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte Download PDF

Info

Publication number
DK3463310T3
DK3463310T3 DK17726906.5T DK17726906T DK3463310T3 DK 3463310 T3 DK3463310 T3 DK 3463310T3 DK 17726906 T DK17726906 T DK 17726906T DK 3463310 T3 DK3463310 T3 DK 3463310T3
Authority
DK
Denmark
Prior art keywords
omega
tablets
active ingredient
amino acid
ingredient content
Prior art date
Application number
DK17726906.5T
Other languages
English (en)
Inventor
Thomas Gottstein
Günter Knaup
Michael Schwarm
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Application granted granted Critical
Publication of DK3463310T3 publication Critical patent/DK3463310T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK17726906.5T 2016-05-25 2017-05-24 Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte DK3463310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16171296 2016-05-25
PCT/EP2017/062592 WO2017202942A1 (en) 2016-05-25 2017-05-24 Tablets with high active ingredient content of omega-3 fatty acid amino acid salts

Publications (1)

Publication Number Publication Date
DK3463310T3 true DK3463310T3 (da) 2023-09-25

Family

ID=56081305

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17726906.5T DK3463310T3 (da) 2016-05-25 2017-05-24 Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte

Country Status (9)

Country Link
US (1) US12115260B2 (da)
EP (1) EP3463310B1 (da)
AU (1) AU2017270134B2 (da)
CA (1) CA3025425C (da)
DK (1) DK3463310T3 (da)
ES (1) ES2956766T3 (da)
PL (1) PL3463310T3 (da)
TW (1) TW201808274A (da)
WO (1) WO2017202942A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220287345A1 (en) * 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
EP4009956A1 (en) * 2019-08-08 2022-06-15 Evonik Operations GmbH Down streaming process for the production of polyunsaturated fatty acid salts
WO2021023850A1 (en) * 2019-08-08 2021-02-11 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
EP3804699A1 (en) * 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
IT1264987B1 (it) 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
US20100215758A1 (en) * 2009-02-25 2010-08-26 Joar Opheim Effervescent nutritional and/or dietary supplement composition

Also Published As

Publication number Publication date
CA3025425A1 (en) 2017-11-30
AU2017270134B2 (en) 2022-09-01
ES2956766T3 (es) 2023-12-27
AU2017270134A1 (en) 2018-12-06
WO2017202942A1 (en) 2017-11-30
CA3025425C (en) 2024-10-01
US20200315970A1 (en) 2020-10-08
EP3463310B1 (en) 2023-07-05
US12115260B2 (en) 2024-10-15
PL3463310T3 (pl) 2023-12-04
EP3463310A1 (en) 2019-04-10
TW201808274A (zh) 2018-03-16

Similar Documents

Publication Publication Date Title
NL301361I2 (nl) olezarsen of farmaceutisch aanvaardbare zouten daarvan
NO2025045I1 (no) Elafibranor and pharmaceutically acceptable salts and esters thereof
EP3735963C0 (en) SELF-EMULSIFYING COMPOSITION OF OMEGA-3 FATTY ACIDS
IL257279A (en) Stable anti-ifnar1 formulation
LT3302565T (lt) Kietos palbociklibo dozavimo formos
IL254353A0 (en) Vaporizer for vaporizing an active ingredient
DK3273942T3 (da) Mikronåleplaster til indgivelse af en aktiv bestanddel til huden
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3355856T3 (da) Oralt administrerede aminosyreformuleringer med modificeret udløsning
DK3116491T3 (da) Farmaceutiske sammensætninger af terapeutisk aktive forbindelser
CL2016002300A1 (es) Combinaciones de principios activos insecticidas y nematocidas
IL253619A0 (en) Encapsulation of high potency active agents
EP3426244C0 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
EP3884939C0 (en) 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND THEIR USES
HUE049437T2 (hu) Hatóanyagként heterociklusos diamino-karboxamid vegyületet tartalmazó gyógyászati készítmény
IL262233B (en) Prodrug of amino acid derivative
PL3463310T3 (pl) Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3
IL260004A (en) Crystalline forms of quinolone analogs and their salts
EP3394099A4 (en) Formulations of Manipulated Anti- IL-10 Antibodies
DK3544584T3 (da) Farmaceutisk parenteral formulering indeholdende cargluminsyre
DK3082795T3 (da) Sammensætninger af omega 3 fedtsyrer til behandling af sygdomme, der involverer skader på nervesystemet
EP3600280A4 (en) 1-AMINO-1-CYCLOPROPANECARBOXYL ACID HYDROCHLORIDE FORMULATIONS
DK3400017T3 (da) Kontinuerlig kompleksering af aktive farmaceutiske ingredienser
PL3452441T3 (pl) Pochodne kwasu alfa-truksylowego i ich kompozycje farmaceutyczne
FR3039396B1 (fr) Base de formulation cosmetique concentree